Skip to main content

Table 2 Comorbidities at baseline

From: Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)

Comorbidities at baseline, n (%)

PF-ILD (n = 14,413)

Arterial hypertension

9193 (63.8)

Gastroesophageal reflux disease

7991 (55.4)

Cardiac arrhythmias

3155 (21.9)

Depression

2953 (20.5)

Congestive heart failure

2886 (20.0)

Chronic coronary disease

2227 (15.5)

Lung cancer

940 (6.5)

Anaemia

826 (5.7)

Pulmonary hypertension

765 (5.3)

Diarrhoea

486 (3.4)

Digital ulcer

475 (3.3)

Osteoporosis

399 (2.8)

Acute coronary syndrome

284 (2.0)

Cirrhosis

172 (1.2)

  1. Baseline was defined as the date of progression
  2. PF-ILD progressive fibrosing interstitial lung disease